Menu

Westlake Corporation (WLK)

$81.07
+6.60 (8.86%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$10.4B

Enterprise Value

$13.6B

P/E Ratio

17.3

Div Yield

2.83%

Rev Growth YoY

-3.2%

Rev 3Y CAGR

+1.0%

Earnings YoY

+25.7%

Earnings 3Y CAGR

-33.1%

Company Profile

At a glance

A Tale of Two Segments in Crisis: Westlake's Performance and Essential Materials (PEM) segment is experiencing an "extended trough" with Q3 2025 EBITDA collapsing to $90 million from $297 million year-over-year, while the Housing and Infrastructure Products (HIP) segment maintains a resilient 20% EBITDA margin and record revenue potential, creating a classic sum-of-parts valuation disconnect that management argues makes the chemical business "free" to investors.

Self-Help is the Only Way Out: With global chlorovinyls oversupply from Asian capacity and weak European demand, Westlake isn't waiting for a cyclical recovery. The company is executing a three-pillar strategy—plant reliability improvements, $200 million in additional structural cost cuts by 2026, and asset optimization including the Pernis facility closure that will generate $100+ million in annual savings—representing the only lever management controls in a commoditized market.

Goodwill Impairment as Mechanical Reality Check: The $727 million non-cash impairment on North American Chlorovinyls goodwill in Q3 2025 signals neither strategic failure nor asset obsolescence, but rather the mathematical consequence of an extended downturn. The fact that physical assets weren't impaired suggests management's conviction that medium-to-long-term demand remains intact, even as near-term pricing power evaporates.

Price Chart

Loading chart...